Skip to main content
SLS
NASDAQ Life Sciences

Cancer Vaccine Data Sends Shares Up 156%, Then $150M Offering Cools the Rally

Tom Rudovsky · Reported by CNBC TV18
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$17.14
Mkt Cap
$1.523B
52W Low
$1.39
52W High
$24.89
52W Position info
1133% above low
Off High info
31% below high
Rel. Volume info
14× avg
Market data snapshot near publication time

SLS has more than doubled off its 52-week low of $1.39 on elevated volume (14× avg).

Summary

SELLAS shares jumped 156% Tuesday, the biggest single-day gain since 2020, after the Phase 3 REGAL trial of galinpepimut-S met its primary overall survival endpoint in second-remission AML. The vaccine cut the risk of death by 41% versus best available treatment, with median overall survival of 24 months against less than 15 months. The stock was up as much as 233% intraday before closing well off that high. The company then launched a $150 million underwritten common stock offering through JPMorgan and TD Cowen, and shares fell 12% in extended trading. Short interest climbed to 29% of the free float after the surge, so a crowded bearish base now sits against a stock that just cleared its binary event. The offering price and terms will set the near-term trading level; the 424B5 prospectus filed Tuesday night is the document to read for the discount.

At the time of this announcement, SLS was trading at $17.14 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $1.39 to $24.89. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: CNBC TV18.


Price Chart

Share this article

Copied!

SLS - Latest Insights

SLS
Nov 17, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $18.03
Real-time Price: $18.08 info
Change: +$0.051 (+0.28%) info
Market Cap: $1.523B info
SLS
Nov 17, 2026, 10:09 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $20.45
Real-time Price: $18.08 info
Change: -$2.37 (-12%) info
Market Cap: $1.523B info
SLS
Nov 17, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
10
Price at Filing: $8.00
Real-time Price: $18.08 info
Change: +$10.08 (+126%) info
Market Cap: $1.523B info
SLS
Nov 12, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $8.01
Real-time Price: $18.08 info
Change: +$10.08 (+126%) info
Market Cap: $1.523B info
SLS
Oct 28, 2026, 8:35 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $12.75
Real-time Price: $18.08 info
Change: +$5.33 (+42%) info
Market Cap: $1.523B info